Literature DB >> 21267140

Estrogen replacement therapy for postmenopausal osteoporosis.

J G Roberts, C E Webber, C A Woolever.   

Abstract

In postmenopausal women, inevitable longitudinal loss of bone mass is increased in association with reduced levels of endogenous estrogen. A review of the health-care literature on therapy for postmenopausal osteoporosis provides strong evidence for prevention and treatment with estrogen/progestogen replacement therapy. This therapy was not associated with endometrial carcinoma.

Entities:  

Year:  1986        PMID： 21267140      PMCID： PMC2327642     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  39 in total

1.  Measurement of skeletal status by noninvasive methods.

Authors:  R B Mazess
Journal:  Calcif Tissue Int       Date:  1979-10-31       Impact factor: 4.333

2.  Granulosatheca cell tumors and endometrial carcinoma; a study of their relationship and a survey of 80 cases.

Authors:  H MANSELL; A T HERTIG
Journal:  Obstet Gynecol       Date:  1955-10       Impact factor: 7.661

3.  Increasing incidence of endometrial cancer in the United States.

Authors:  N S Weiss; D R Szekely; D F Austin
Journal:  N Engl J Med       Date:  1976-06-03       Impact factor: 91.245

4.  Osteoporosis of the slender smoker. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity.

Authors:  H W Daniell
Journal:  Arch Intern Med       Date:  1976-03

5.  Physiological senile involution and pathological rarefaction of bone. Quantitative and comparative histological data.

Authors:  P Meunier; P Courpron; C Edouard; J Bernard; J Bringuier; G Vignon
Journal:  Clin Endocrinol Metab       Date:  1973-07

6.  Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study.

Authors:  T A Hutchinson; S M Polansky; A R Feinstein
Journal:  Lancet       Date:  1979-10-06       Impact factor: 79.321

7.  Menopausal estrogen therapy and hip fractures.

Authors:  A Paganini-Hill; R K Ross; V R Gerkins; B E Henderson; M Arthur; T M Mack
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

8.  Endometrial disease after treatment with oestrogens and progestogens in the climacteric.

Authors:  M E Paterson; T Wade-Evans; D W Sturdee; M H Thom; J W Studd
Journal:  Br Med J       Date:  1980-03-22

9.  An epidemiologic study of hip fracture in postmenopausal women.

Authors:  N Kreiger; J L Kelsey; T R Holford; T O'Connor
Journal:  Am J Epidemiol       Date:  1982-07       Impact factor: 4.897

10.  Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

Authors:  B L Riggs; E Seeman; S F Hodgson; D R Taves; W M O'Fallon
Journal:  N Engl J Med       Date:  1982-02-25       Impact factor: 91.245
View more
  1 in total

1.  Sargassum integerrimum inhibits oestrogen deficiency and hyperlipidaemia-induced bone loss by upregulating nuclear factor (erythroid-derived 2)-like 2 in female rats.

Authors:  Kefeng Wu; Zhongqin Gong; Liyi Zou; Hua Ye; Changxiu Wang; Yangchun Liu; Yan Liang; Yanping Li; Jianwei Ren; Liao Cui; Yi Liu
Journal:  J Orthop Translat       Date:  2019-03-27       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.